logo
Plus   Neg
Share
Email

High Arctic Energy Gets Necessary Approvals To Conduct Normal Course Issuer Bid

High Arctic Energy Services Inc. (HWO.TO) said it has made the necessary filings, and received the necessary approvals to conduct a normal course issuer bid through the facilities of the Toronto Stock Exchange.

The TSX has accepted the Corporation's notice to conduct the normal course issuer bid to purchase outstanding common shares on the open market, in accordance with the rules of the TSX. As approved by the TSX, the Corporation is authorized to purchase up to 2.48 million common shares, representing approximately 5% of the currently issued and outstanding common shares of the Corporation.

As of today's date, there are 49.62 million common shares outstanding. On any trading day, High Arctic will not purchase more than 6,248 common shares, other than through block purchase exceptions.

The Corporation is authorized to make purchases during the period from March 23, 2012 to March 22, 2013, or until such earlier time as the normal course issuer bid is completed or terminated at the option of the Corporation.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT